AtheroGenics releases diabetes data
This is a discussion on AtheroGenics releases diabetes data within the Biotechnology News forum, part of the Industry News and Updates category; AtheroGenics has released Phase III trial data showing that the patients who did not have diabetes when beginning treatment and ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-23-2008, 03:17 PM
|
|||
|
|||
AtheroGenics releases diabetes data
AtheroGenics has released Phase III trial data showing that the patients who did not have diabetes when beginning treatment and assigned to the AGI-1067 dosage group benefited by a 63 percent reduction in progression to new onset diabetes, compared to the patients receiving placebo. Release
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Hollis-Eden touts new diabetes data; Nastech announces positive insulin report | industry_news | Biotechnology News | 0 | 06-10-2008 08:52 AM |
| Phase III data sinks Keryx's diabetes drug | industry_news | Biotechnology News | 0 | 03-11-2008 02:26 PM |
© 2008 DrugManagementForum™ powered by |
 |